Maridebart Cafraglutide (MariTide): The Newest Contender in Weight-Loss Peptides
The last decade has seen an explosion of new therapies for obesity and metabolic disease, with GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) dominating headlines and prescriptions. These medications have redefined what’s...